189 related articles for article (PubMed ID: 7944004)
41. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
[TBL] [Abstract][Full Text] [Related]
42. [Aqueous levels of eosinophil cationic protein and major basic protein in patients with retinal detachment associated with atopic dermatitis].
Matsuda H; Katsura H; Ishida S; Inoue M
Nippon Ganka Gakkai Zasshi; 1998 Mar; 102(3):189-92. PubMed ID: 9558841
[TBL] [Abstract][Full Text] [Related]
43. Elevation of serum major basic protein in patients with atopic dermatitis.
Morita H; Yamamoto K; Kitano Y
J Dermatol Sci; 1995 May; 9(3):165-8. PubMed ID: 8664213
[TBL] [Abstract][Full Text] [Related]
44. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age.
Breuer K; Kapp A; Werfel T
Allergy; 2001 Aug; 56(8):780-4. PubMed ID: 11488674
[TBL] [Abstract][Full Text] [Related]
45. Increased sensitivity of eosinophils for eosinophilopoietic cytokines in atopic dermatitis.
Kato K
Kurume Med J; 1995; 42(4):187-98. PubMed ID: 8667590
[TBL] [Abstract][Full Text] [Related]
46. [Detection of ICAM-1 and RANTES in infants with bronchiolitis].
Zou LP; Zhang SL
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):181-3. PubMed ID: 20350425
[TBL] [Abstract][Full Text] [Related]
47. Eosinophil cationic protein in atopic eczema.
Jakob T; Hermann K; Ring J
Arch Dermatol Res; 1991; 283(1):5-6. PubMed ID: 2059059
[No Abstract] [Full Text] [Related]
48. Eosinophil chemiluminescence response to cytokines and opsonized zymosans in atopic dermatitis.
Miyasato M; Taguchi K; Tsuda S; Kitamura N; Kato K
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):24-6. PubMed ID: 8155999
[TBL] [Abstract][Full Text] [Related]
49. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
Kägi MK; Joller-Jemelka H; Wüthrich B
Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
[TBL] [Abstract][Full Text] [Related]
50. Chronologic analysis of eosinophil granule protein deposition and cell adhesion molecule expression in mite allergen-induced dermatitis in atopic subjects.
Wakugawa M; Nakagawa H; Yamada N; Tamaki K
Int Arch Allergy Immunol; 1996; 111 Suppl 1():5-11. PubMed ID: 8906103
[TBL] [Abstract][Full Text] [Related]
51. The role of eosinophils and eosinophil cationic protein in monitoring oral challenge tests in children with food-sensitive atopic dermatitis.
Niggemann B; Beyer K; Wahn U
J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):963-71. PubMed ID: 7798544
[TBL] [Abstract][Full Text] [Related]
52. Leptin and Atopic Dermatitis in Korean Elementary School Children.
Seo S; Yoon WS; Cho Y; Park SH; Choung JT; Yoo Y
Iran J Allergy Asthma Immunol; 2016 Apr; 15(2):138-44. PubMed ID: 27090367
[TBL] [Abstract][Full Text] [Related]
53. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
Czech W; Krutmann J; Schöpf E; Kapp A
Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
[TBL] [Abstract][Full Text] [Related]
54. Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum IgE levels.
Dhar S; Malakar R; Chattopadhyay S; Dhar S; Banerjee R; Ghosh A
Indian J Dermatol Venereol Leprol; 2005; 71(4):246-9. PubMed ID: 16394432
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal case analysis in atopic dermatitis.
Helmbold P; Gaisbauer G; Kupfer J; Haustein UF
Acta Derm Venereol; 2000; 80(5):348-52. PubMed ID: 11200832
[TBL] [Abstract][Full Text] [Related]
56. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis.
Fölster-Holst R; Henseler T; Wehde J; Lemke H; Weichenthal M; Christophers E; Hansen HP
Acta Derm Venereol; 2002; 82(4):245-8. PubMed ID: 12361126
[TBL] [Abstract][Full Text] [Related]
57. The relationship between eosinophils, OKT6-positive cells and house dust mite (HDM) antigens in naturally occurring lesions of atopic dermatitis.
Maeda K; Yamamoto K; Tanaka Y; Anan S; Yoshida H
J Dermatol Sci; 1992 May; 3(3):151-6. PubMed ID: 1498094
[TBL] [Abstract][Full Text] [Related]
58. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity.
Walker C; Kägi MK; Ingold P; Braun P; Blaser K; Bruijnzeel-Koomen CA; Wüthrich B
Clin Exp Allergy; 1993 Feb; 23(2):145-53. PubMed ID: 8448682
[TBL] [Abstract][Full Text] [Related]
59. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis.
Krutmann J; Czech W; Diepgen T; Niedner R; Kapp A; Schöpf E
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):225-30. PubMed ID: 1552057
[TBL] [Abstract][Full Text] [Related]
60. A role for eosinophils in the pathogenesis of skin lesions in patients with food-sensitive atopic dermatitis.
Magnarin M; Knowles A; Ventura A; Vita F; Fanti L; Zabucchi G
J Allergy Clin Immunol; 1995 Aug; 96(2):200-8. PubMed ID: 7636058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
